Screening colonoscopy rates for colorectal cancer increased in low-income Latino populations when accompanied by patient navigation.
The FDA has granted a priority review to a new drug application for pemigatinib as a treatment for patients with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
Predictive models demonstrated the ability to anticipate adverse opioid-related outcomes among cancer survivors.
A quality improvement study indicated that nudges in the electronic health record were associated with a significant increase in clinician ordering of screening tests for breast and colorectal cancer.
A rare occurrence, cancer in the esophagus requires an individualized treatment plan.
A postsurgical circulating tumor DNA analysis after surgery and adjuvant chemotherapy may identify patients with stage III colorectal cancer at high risk of recurrence.
A multi-institutional pilot feasibility study looks at pencil beam scanning proton beam chemoradiation therapy with 5-fluorouracil
and mitomycin-C for definitive treatment of carcinoma of the anal canal.
A new study found artificial intelligence-based diagnostics could help with better diagnoses for upper gastrointestinal cancers.
Laparoscopy-assisted distal gastrectomy offered better short-term, post-surgical outcomes for patients with locally advanced gastric cancer who were undergoing neoadjuvant chemotherapy.
Clinicians discuss appropriate evaluation and choice of management strategies for cholangiocarcinoma.